View in EDS

MDMA-assisted therapy for moderate to severe PTSD: a randomized, placebo-controlled phase 3 trial.

Saved in:
Bibliographic Details
Title: MDMA-assisted therapy for moderate to severe PTSD: a randomized, placebo-controlled phase 3 trial.
Authors: Mitchell JM; Neuroscape, Department of Neurology, University of California, San Francisco, San Francisco, CA, USA. jennifer.mitchell@ucsf.edu.; Department of Psychiatry and Behavioral Sciences, University of California, San Francisco, San Francisco, CA, USA. jennifer.mitchell@ucsf.edu.; Department of Veterans Affairs, Research Service, San Francisco VA Medical Center, San Francisco, CA, USA. jennifer.mitchell@ucsf.edu., Ot'alora G M; Aguazul-Bluewater, Inc, Boulder, CO, USA., van der Kolk B; Boston University School of Medicine, Boston, MA, USA., Shannon S; Wholeness Center, Fort Collins, CO, USA., Bogenschutz M; Department of Psychiatry, New York University Grossman School of Medicine, New York, NY, USA., Gelfand Y; Zen Therapeutic Solutions, Mt. Pleasant, SC, USA., Paleos C; Nautilus Sanctuary, New York, NY, USA., Nicholas CR; Department of Family Medicine and Community Health, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA., Quevedo S; Department of Psychiatry and Behavioral Sciences, University of California, San Francisco, San Francisco, CA, USA.; San Francisco Insight and Integration Center, San Francisco, CA, USA., Balliett B; New School Research, LLC, Los Angeles, CA, USA., Hamilton S; MAPS Public Benefit Corporation, San Jose, CA, USA., Mithoefer M; Medical University of South Carolina, Charleston, SC, USA., Kleiman S; Kleiman Consulting and Psychological Services, PC, Ivyland, PA, USA., Parker-Guilbert K; KPG Psychological Services, LLC, Brunswick, ME, USA., Tzarfaty K; University of Haifa, Haifa, Israel.; MAPS Israel, Hod Hasharon, Israel., Harrison C; MAPS Public Benefit Corporation, San Jose, CA, USA., de Boer A; Tulip Medical Consulting, LLC, Port Townsend, WA, USA., Doblin R; Multidisciplinary Association for Psychedelic Studies (MAPS), San Jose, CA, USA., Yazar-Klosinski B; MAPS Public Benefit Corporation, San Jose, CA, USA.
Corporate Authors: MAPP2 Study Collaborator Group
Source: Nature medicine [Nat Med] 2023 Oct; Vol. 29 (10), pp. 2473-2480. Date of Electronic Publication: 2023 Sep 14.
Publication Type: Randomized Controlled Trial; Clinical Trial, Phase III; Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Nature Publishing Company Country of Publication: United States NLM ID: 9502015 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1546-170X (Electronic) Linking ISSN: 10788956 NLM ISO Abbreviation: Nat Med Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 37709999
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: MDMA-assisted therapy for moderate to severe PTSD: a randomized, placebo-controlled phase 3 trial.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Mitchell+JM%22">Mitchell JM</searchLink>; Neuroscape, Department of Neurology, University of California, San Francisco, San Francisco, CA, USA. jennifer.mitchell@ucsf.edu.; Department of Psychiatry and Behavioral Sciences, University of California, San Francisco, San Francisco, CA, USA. jennifer.mitchell@ucsf.edu.; Department of Veterans Affairs, Research Service, San Francisco VA Medical Center, San Francisco, CA, USA. jennifer.mitchell@ucsf.edu.<br /><searchLink fieldCode="AU" term="%22Ot'alora+G+M%22">Ot'alora G M</searchLink>; Aguazul-Bluewater, Inc, Boulder, CO, USA.<br /><searchLink fieldCode="AU" term="%22van+der+Kolk+B%22">van der Kolk B</searchLink>; Boston University School of Medicine, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Shannon+S%22">Shannon S</searchLink>; Wholeness Center, Fort Collins, CO, USA.<br /><searchLink fieldCode="AU" term="%22Bogenschutz+M%22">Bogenschutz M</searchLink>; Department of Psychiatry, New York University Grossman School of Medicine, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Gelfand+Y%22">Gelfand Y</searchLink>; Zen Therapeutic Solutions, Mt. Pleasant, SC, USA.<br /><searchLink fieldCode="AU" term="%22Paleos+C%22">Paleos C</searchLink>; Nautilus Sanctuary, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Nicholas+CR%22">Nicholas CR</searchLink>; Department of Family Medicine and Community Health, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA.<br /><searchLink fieldCode="AU" term="%22Quevedo+S%22">Quevedo S</searchLink>; Department of Psychiatry and Behavioral Sciences, University of California, San Francisco, San Francisco, CA, USA.; San Francisco Insight and Integration Center, San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Balliett+B%22">Balliett B</searchLink>; New School Research, LLC, Los Angeles, CA, USA.<br /><searchLink fieldCode="AU" term="%22Hamilton+S%22">Hamilton S</searchLink>; MAPS Public Benefit Corporation, San Jose, CA, USA.<br /><searchLink fieldCode="AU" term="%22Mithoefer+M%22">Mithoefer M</searchLink>; Medical University of South Carolina, Charleston, SC, USA.<br /><searchLink fieldCode="AU" term="%22Kleiman+S%22">Kleiman S</searchLink>; Kleiman Consulting and Psychological Services, PC, Ivyland, PA, USA.<br /><searchLink fieldCode="AU" term="%22Parker-Guilbert+K%22">Parker-Guilbert K</searchLink>; KPG Psychological Services, LLC, Brunswick, ME, USA.<br /><searchLink fieldCode="AU" term="%22Tzarfaty+K%22">Tzarfaty K</searchLink>; University of Haifa, Haifa, Israel.; MAPS Israel, Hod Hasharon, Israel.<br /><searchLink fieldCode="AU" term="%22Harrison+C%22">Harrison C</searchLink>; MAPS Public Benefit Corporation, San Jose, CA, USA.<br /><searchLink fieldCode="AU" term="%22de+Boer+A%22">de Boer A</searchLink>; Tulip Medical Consulting, LLC, Port Townsend, WA, USA.<br /><searchLink fieldCode="AU" term="%22Doblin+R%22">Doblin R</searchLink>; Multidisciplinary Association for Psychedelic Studies (MAPS), San Jose, CA, USA.<br /><searchLink fieldCode="AU" term="%22Yazar-Klosinski+B%22">Yazar-Klosinski B</searchLink>; MAPS Public Benefit Corporation, San Jose, CA, USA.
– Name: AuthorCorporate
  Label: Corporate Authors
  Group: Au
  Data: <searchLink fieldCode="CA" term="%22MAPP2+Study+Collaborator+Group%22">MAPP2 Study Collaborator Group</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229502015%22">Nature medicine</searchLink> [Nat Med] 2023 Oct; Vol. 29 (10), pp. 2473-2480. <i>Date of Electronic Publication: </i>2023 Sep 14.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Randomized Controlled Trial; Clinical Trial, Phase III; Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Publishing+Company%22">Nature Publishing Company </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9502015 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1546-170X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2210788956%22">10788956 </searchLink><i>NLM ISO Abbreviation: </i>Nat Med <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37709999
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s41591-023-02565-4
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 2473
    Titles:
      – TitleFull: MDMA-assisted therapy for moderate to severe PTSD: a randomized, placebo-controlled phase 3 trial.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Mitchell JM
      – PersonEntity:
          Name:
            NameFull: Ot'alora G M
      – PersonEntity:
          Name:
            NameFull: van der Kolk B
      – PersonEntity:
          Name:
            NameFull: Shannon S
      – PersonEntity:
          Name:
            NameFull: Bogenschutz M
      – PersonEntity:
          Name:
            NameFull: Gelfand Y
      – PersonEntity:
          Name:
            NameFull: Paleos C
      – PersonEntity:
          Name:
            NameFull: Nicholas CR
      – PersonEntity:
          Name:
            NameFull: Quevedo S
      – PersonEntity:
          Name:
            NameFull: Balliett B
      – PersonEntity:
          Name:
            NameFull: Hamilton S
      – PersonEntity:
          Name:
            NameFull: Mithoefer M
      – PersonEntity:
          Name:
            NameFull: Kleiman S
      – PersonEntity:
          Name:
            NameFull: Parker-Guilbert K
      – PersonEntity:
          Name:
            NameFull: Tzarfaty K
      – PersonEntity:
          Name:
            NameFull: Harrison C
      – PersonEntity:
          Name:
            NameFull: de Boer A
      – PersonEntity:
          Name:
            NameFull: Doblin R
      – PersonEntity:
          Name:
            NameFull: Yazar-Klosinski B
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 10
              Text: 2023 Oct
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-electronic
              Value: 1546-170X
          Numbering:
            – Type: volume
              Value: 29
            – Type: issue
              Value: 10
          Titles:
            – TitleFull: Nature medicine
              Type: main
ResultId 1